EarlyDiagnostics Information

View Top Employees from EarlyDiagnostics

EarlyDx is committed to providing cutting-edge non-invasive genomics technologies and best-in-class early disease diagnostics. Our proprietary cfDNA-based technologies, in combination with powerful AI algorithms, have shown great potential to transform non-invasive biomarker discovery, diagnostics, and precision medicine for almost any diseases, including cancers, aging, metabolic diseases, autoimmune diseases, imprinting diseases, and neurological diseases. Our key cfDNA-based best-in-class technologies include: 1. cfMethyl-seq: a powerful and cost-effective NGS solution to profile the cfDNA methylome 2. cfSNV: a cutting-edge computational tool to accurately call mutations directly from blood 3. cfTrack: for non-invasive monitoring of cancer MRD, recurrence, and evolution 4. EarlyDx-Cloud: a comprehensive bioinformatics data analysis platform for liquid biopsy Please check out our relevant publications in details: https://earlydx.com/technologies/publications/

Website	https://www.earlydx.com
Employees	7 (6 on RocketReach)
Founded	2017
Address	570 Westwood Plaza Building 114 Mail Code: 722710, Los Angeles, California 90095, US
Phone	+1 262-673-6815
Technologies	JavaScript , HTML , PHP +9 more (view full list)
Industry	Biotechnology Research, Decision/Risk Analysis
Keywords	Early Cancer Detection, Early Disease Detection, Genomics Testing, Liquid Biopsy, Cancer Diagnostics, Ai Powered Diagnostics, Dna Sequencing, Molecular Diagnostics, Predictive Diagnostics, Non Invasive Diagnostics, Next Generation Sequencing, Precision Oncology, In Vitro Diagnostics, Disease Screening, Personalized Medicine, Diagnostic Testing, Medical Diagnostics, Health Diagnostics
Competitors	Natera, Exact Sciences, Guardant Health, QIAGEN, GRAIL, Foundation Medicine, Caris Life Sciences, Invitae, Freenome, Biodesix, Inc. +37 more (view full list)